Charanjit Aulakh

Array ( [id] => 745889 [patent_doc_number] => 07026483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Forms of cabergoline' [patent_app_type] => utility [patent_app_number] => 10/827955 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8190 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026483.pdf [firstpage_image] =>[orig_patent_app_number] => 10827955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122947 [patent_doc_number] => 20050014776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Steroidal compounds for inhibiting steroid sulphatase' [patent_app_type] => utility [patent_app_number] => 10/825758 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 49853 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014776.pdf [firstpage_image] =>[orig_patent_app_number] => 10825758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014821 [patent_doc_number] => 06894165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Imidazonaphthyridines' [patent_app_type] => utility [patent_app_number] => 10/824232 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43060 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894165.pdf [firstpage_image] =>[orig_patent_app_number] => 10824232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786799 [patent_doc_number] => 20060205774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => '4-(4-(Heterocyclylakoxy) phenyl-1-(heterocyclyl-carbonyl) piperidine derivavites and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer\'s' [patent_app_type] => utility [patent_app_number] => 10/551985 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12892 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205774.pdf [firstpage_image] =>[orig_patent_app_number] => 10551985 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 545005 [patent_doc_number] => 07163948 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs' [patent_app_type] => utility [patent_app_number] => 10/820487 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9557 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163948.pdf [firstpage_image] =>[orig_patent_app_number] => 10820487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678408 [patent_doc_number] => 20060183764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Combination of gh secret agogues and pde4 inhibitors for the treatment of alzheimers disease' [patent_app_type] => utility [patent_app_number] => 10/552367 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5301 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183764.pdf [firstpage_image] =>[orig_patent_app_number] => 10552367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972238 [patent_doc_number] => 06936623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Pyrano[2,3-C]imidazo[-1,2-A]pyridine derivatives for the treatment of gastrointestinal disorders' [patent_app_type] => utility [patent_app_number] => 10/811496 [patent_app_country] => US [patent_app_date] => 2004-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6929 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936623.pdf [firstpage_image] =>[orig_patent_app_number] => 10811496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5678548 [patent_doc_number] => 20060183904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/548350 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50529 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183904.pdf [firstpage_image] =>[orig_patent_app_number] => 10548350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051978 [patent_doc_number] => 20070032523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Chemical compounds' [patent_app_type] => utility [patent_app_number] => 10/551493 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21141 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032523.pdf [firstpage_image] =>[orig_patent_app_number] => 10551493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995145 [patent_doc_number] => 20070010490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'T-type calcium channel blockers' [patent_app_type] => utility [patent_app_number] => 10/549510 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7825 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010490.pdf [firstpage_image] =>[orig_patent_app_number] => 10549510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341673 [patent_doc_number] => 07501431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Physiologically active substances PF1270A, B and C substances' [patent_app_type] => utility [patent_app_number] => 10/551417 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5466 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501431.pdf [firstpage_image] =>[orig_patent_app_number] => 10551417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711637 [patent_doc_number] => 07057045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Process for obtaining 17β-(substituted)-3-oxo-Δ1,2-4-azasteroids and intermediates' [patent_app_type] => utility [patent_app_number] => 10/810128 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6489 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/057/07057045.pdf [firstpage_image] =>[orig_patent_app_number] => 10810128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808359 [patent_doc_number] => 20060094714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Compounds and their use to treat diabetes and related disorders' [patent_app_type] => utility [patent_app_number] => 10/543070 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16660 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094714.pdf [firstpage_image] =>[orig_patent_app_number] => 10543070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 993727 [patent_doc_number] => 06916826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Substituted imidazo[1,2-a]pyridine derivatives' [patent_app_type] => utility [patent_app_number] => 10/809068 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6711 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916826.pdf [firstpage_image] =>[orig_patent_app_number] => 10809068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378728 [patent_doc_number] => 20040220223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them' [patent_app_type] => new [patent_app_number] => 10/805733 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41939 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220223.pdf [firstpage_image] =>[orig_patent_app_number] => 10805733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276403 [patent_doc_number] => 20040235854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => '1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity' [patent_app_type] => new [patent_app_number] => 10/490019 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8549 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235854.pdf [firstpage_image] =>[orig_patent_app_number] => 10490019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410015 [patent_doc_number] => 20040176326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof' [patent_app_type] => new [patent_app_number] => 10/803724 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12431 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176326.pdf [firstpage_image] =>[orig_patent_app_number] => 10803724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410901 [patent_doc_number] => 20040176406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Pyrido [2,1-a] isoquinoline derivatives' [patent_app_type] => new [patent_app_number] => 10/800991 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16115 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176406.pdf [firstpage_image] =>[orig_patent_app_number] => 10800991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341757 [patent_doc_number] => 07501515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Polymorphic form of 17-β-(N-ter. butyl carbamoyl)-4-aza-5-α-androst-1-en-3-one' [patent_app_type] => utility [patent_app_number] => 10/801069 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3551 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501515.pdf [firstpage_image] =>[orig_patent_app_number] => 10801069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924132 [patent_doc_number] => 20060241083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Novel heteroaryl phosphonates as cardioprotective agents' [patent_app_type] => utility [patent_app_number] => 10/549505 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12559 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241083.pdf [firstpage_image] =>[orig_patent_app_number] => 10549505 [rel_patent_id] =>[rel_patent_doc_number] =>)